医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Amendment of Tender Offer Registration Statement for Benesse Holdings, Inc. (Securities Code: 9783) by Bloom 1 K.K.

2024年02月16日 PM03:15
このエントリーをはてなブックマークに追加


 

TOKYO

We hereby announce that Bloom 1 K.K. filed the attached Amendment of Tender Offer Registration Statement today.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240215925543/en/

(Attachment)
Amendment of Tender Offer Registration Statement for Benesse Holdings, Inc. (Securities Code: 9783) by Bloom 1 K.K. dated February 16, 2024

View source version on businesswire.com: https://www.businesswire.com/news/home/20240215925543/en/

CONTACT

KRIK (PR Agent)

Koshida: +81-70-8793-3990

Sugiyama: +81-70-8793-3989

同じカテゴリーの記事 

  • Ifinatamab Deruxtecan Continues to Demonstrate Promising Objective Response Rates in Patients with Extensive-Stage Small Cell Lung Cancer in IDeate-Lung01 Phase 2 Trial
  • Huonslab Announces Positive Results from In Vivo comparative PK study of Trastuzumab/HyDIFFUZETM compared with marketed rHuPH20 co-formulation with Trastuzumab
  • Rapid Medical™、TIGERTRIEVER™13を用いたDISTALS臨床試験の中間安全性解析で、中血管閉塞の安全性の懸念がないことを報告
  • Amneal and Shilpa Announce U.S. FDA Approval of BORUZU™, the First Ready-to-Use Version of Bortezomib for subcutaneous administration
  • JCR Pharmaceuticals’ Data Presentations at SSIEM Annual Symposium 2024 Highlight Investigational Treatments for Lysosomal Storage Disorders